You Searched For "USFDA warning letter against Aurobindo Pharma" and got 20 results
Sort By:
Market closing: Sun Pharma, Hero Moto lose as fertiliser stocks shine
Nifty and Sensex closed on a positive note. Sun Pharma and HDFC Life were amongst the day's losers.…
Market Morning: Sensex, Nifty off to a muted start, Sun Pharma, KEI in spotlight
Nifty50 and Sensex started slow with Nifty50 at 23,661.15 points. Sun Pharma stocks rose by 0.36% a…
Mylan, Dr Reddy's, Aurobindo, and Torrent Pharma can't sell generic Gilenya that is patented by Novartis
A US court has ordered generic drug makers including Mylan, Dr Reddy's Laboratories, Aurobindo Ph…
USFDA rescinds VAI status for Aurobindo Pharma's Hyderabad unit
The company has received a communication that the inspection conducted by the US Food and Drug Adm…
PTI
Market says Torrent better fit for Cipla as Dr Reddy’s and Blackstone join fray
The promoters of one of India’s oldest pharma companies Cipla want to exit the business, and it’s n…
USFDA cautions Aurobindo Pharma's oral solids formulation facility of regulatory action
New Delhi, Jan 30 () Drug firm Aurobindo Pharma on Thursday reported that the US health regulator h…
PTI
The FDA recalled eye drops that could cause blindness, days after warning against others from Amazon. Here's a list of 34 products you shouldn't use.
Twenty seven of the eye drops were recalled because they could cause blindness or infections, while…
Kim Schewitz
Aurobindo Pharma Inc recalls Mirtazapine tablets in US
The company is recalling lot number 03119002A3 of tablets to the consumer level, it added.
PTI
A frightening new book on the safety of generic drugs could send India’s pharma industry into an even deeper pit
Drug makers in India have relied on Americans to buy a big chunk their produce for a long time now…
USFDA red flags Torrent Pharma's US-based plant for manufacturing violations
New Delhi, Nov 24 () The American health regulator has pulled up Torrent Pharmaceuticals' US-based …
PTI
Indian pharma industry likely to grow at 10-13 pc in FY'21: Icra
"The Indian pharmaceutical industry's growth remained stable at 12.2 per cent during H1 FY2020 led …
PTI
A revolving door between FDA and the pharma industry raises questions about 'whether regulators indefatigably act in the public interest'
Dr. Vinay Prasad, a professor of medicine at the Oregon Health and Science University, told Busines…
Lydia Ramsey
Minority shareholders must grin and bear it when promoters wash dirty laundry in public
The Raymond family drama has taken its toll on minority shareholders of the company because this ca…
Indian markets open higher on indications of US Fed slowing interest rate hikes – Tata Consumer, Keystone Realtors, Biocon in focus
Sensex and Nifty50 opened in the green for the third consecutive day amid positive cues from global…
Top stock movers —ITC, Future Retail, Vedanta, Wipro, Premier Explosives, Shilpa Medicare and more
Indian stock market indices Sensex rallied nearly 400 points in opening trade on Monday, led by gai…
The FDA is broken. It's controversial approval of an ineffective new Alzheimer's drug proves the agency puts profit over public health.
Because of how drug research is funded and the profit incentives of the FDA, most newly-approved dr…
P.E. Moskowitz
A self-styled archbishop who got banned from YouTube has been charged with selling a toxic bleach as a COVID-19 cure
Mark Grenon and his three sons face federal charges after allegedly promoting toxic bleach as a "mi…
Tom Porter
How Americans waged war on the scientists trying to save them
The pandemic brought about personal attacks on scientists and public-health officials. That isn't g…
Aria Bendix
PFIZER SHOT GETS OK: US regulators greenlight first coronavirus vaccine for emergency use
Twenty million people in the US could get a coronavirus shot this month, starting with frontline he…
Andrew Dunn
We're repeating one of the worst mistakes of the Ebola outbreak in the hunt for a coronavirus cure
"We have no reliable data" on potential coronavirus treatments, one researcher said. Here's how tha…